NERV
Minerva Neurosciences Inc
NASDAQ: NERV · HEALTHCARE · BIOTECHNOLOGY
$6.47
+1.25% today
Updated 2026-04-30
Market cap
$281.90M
P/E ratio
—
P/S ratio
1.87x
EPS (TTM)
$-34.67
Dividend yield
—
52W range
$1 – $9
Volume
0.3M
Minerva Neurosciences Inc (NERV) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $41.18M | $41.18M | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Revenue growth (YoY) | — | — | — | — | — | — | — | — | — | +0.0% | -100.0% | — | — | — | — |
| Cost of revenue | — | — | — | $0.00 | $17276.00 | $16530.00 | $11094.00 | $17467.00 | $161507.00 | $176177.00 | $101786.00 | $8513.00 | $30982.00 | $22469.00 | $5442.00 |
| Gross profit | — | — | — | $0.00 | $-17276.00 | $-16530.00 | $-11094.00 | $-17467.00 | $-162000.00 | $41.18M | $-102000.00 | $-8513.00 | $-30982.00 | $-22469.00 | $-5442.00 |
| Gross margin | — | — | — | — | — | — | — | — | -0.4% | 100.0% | — | — | — | — | — |
| R&D | $592966.00 | $550360.00 | $708489.00 | $42.91M | $18.53M | $20.44M | $30.26M | $34.89M | $58.12M | $22.04M | $32.04M | $14.65M | $12.71M | $11.90M | $5.76M |
| SG&A | — | $1.03M | $2.47M | $11.96M | $7.58M | $9.75M | $10.91M | $16.84M | $17.74M | $17.29M | $13.33M | $10.58M | $10.41M | $9.95M | $9.34M |
| Operating income | $-1.13M | $-1.58M | $-3.17M | $-54.87M | $-26.11M | $-30.19M | $-41.17M | $-51.73M | $-75.86M | $1.85M | $-45.37M | $-25.23M | $-23.12M | $-21.85M | $-15.10M |
| Operating margin | — | — | — | — | — | — | — | — | -184.2% | 4.5% | — | — | — | — | — |
| EBITDA | $-1.12M | $-1.58M | $-3.20M | $-54.81M | $-26.01M | $-30.00M | $-40.27M | $-50.04M | $-74.28M | $2.12M | $-45.28M | $-24.69M | $-21.69M | $6.02M | $-15.10M |
| EBITDA margin | — | — | — | — | — | — | — | — | -180.4% | 5.1% | — | — | — | — | — |
| EBIT | — | $-1.58M | $-3.20M | $-54.84M | $-26.03M | $-30.02M | $-40.29M | $-50.06M | $-74.44M | $1.94M | $-45.38M | $-24.70M | $-21.72M | $6.00M | $-15.11M |
| Interest expense | — | $0.00 | $59608.00 | $2.05M | $1.05M | $1.03M | $614264.00 | $110448.00 | $1.59M | $0.00 | $6.33M | $7.41M | $8.28M | $4.56M | $0.00 |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-1.12M | $-1.58M | $-3.26M | $-56.90M | $-27.08M | $-31.05M | $-31.52M | $-50.17M | $-72.18M | $1.94M | $-49.91M | $-32.11M | $-30.01M | $1.44M | $-293.42M |
| Net income growth (YoY) | — | -40.9% | -106.2% | -1644.4% | +52.4% | -14.6% | -1.5% | -59.2% | -43.9% | +102.7% | -2671.1% | +35.7% | +6.6% | +104.8% | -20492.7% |
| Profit margin | — | — | — | — | — | — | — | — | -175.3% | 4.7% | — | — | — | — | — |